Inovio Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
91.5 M |
Public Float |
84.97 M |
Inovio Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1 |
Market Cap |
$296.06 M |
Shares Outstanding |
98.03 M |
Public Float |
89.22 M |
Address |
660 West Germantown Pike Plymouth Meeting Pennsylvania 19462 United States |
Employees | - |
Website | http://www.inovio.com |
Updated | 07/08/2019 |
Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA. |